March 18th 2025
A recent study identified distinct gene signatures in placentae from gestational diabetes and pregestational diabetes pregnancies, offering potential for improved diagnosis and treatment strategies.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
AI helps improve detection of congenital heart defects on prenatal ultrasounds
January 31st 2025AI-assisted software improves clinicians' detection of congenital heart defects in prenatal ultrasounds, enhancing accuracy, confidence, and speed, according to a study presented at SMFM's Annual Pregnancy Meeting.
Read More
Statewide initiative improves opioid use disorder care for pregnant patients
January 29th 2025The Mothers and Newborns affected by Opioids - Obstetric initiative significantly increased screening, treatment access, and naloxone counseling for pregnant patients with opioid use disorder, enhancing care and reducing racial disparities.
Read More
New guidelines show better outcomes for managing hematological malignancies in pregnancy
January 24th 2025Discover updated strategies for treating leukemia and lymphomas during pregnancy, emphasizing delayed delivery, chemotherapy safety, and multidisciplinary care for optimal maternal and fetal health.
Watch
Study highlights need for interventions to prevent postpartum smoking relapse
January 21st 2025Smoking cessation during pregnancy not only reduces pregnancy complications but also lowers the risk of relapse and new smoking initiation in the first postpartum year, according to a recent study.
Read More
Radon exposure linked to increased risk of gestational diabetes
January 20th 2025A new study reveals that high radon exposure, especially when combined with smoking or air pollution, significantly raises the risk of gestational diabetes, highlighting the impact of environmental factors on maternal health.
Watch
High opioid use disorder and severe maternal morbidity rates reported among Medicaid patients
January 8th 2025Pregnant patients with opioid use disorder enrolled in Medicaid face significantly increased risks of severe maternal morbidity, underscoring the need for targeted state Medicaid interventions.
Read More